The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients.
第一作者:
Marco,Bolis
第一单位:
Laboratory of Molecular Biology, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Milano, Italy.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);CCAAT增强子结合蛋白类(CCAAT-Enhancer-Binding Proteins);染色体倒位(Chromosome Inversion);决策树(Decision Trees);基因表达谱(Gene Expression Profiling);基因表达调控, 白血病(Gene Expression Regulation, Leukemic);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);突变(Mutation);试验预期值(Predictive Value of Tests);预后(Prognosis);易位, 遗传(Translocation, Genetic);治疗结果(Treatment Outcome);维甲酸(Tretinoin)
DOI
10.1038/s41408-019-0241-5
PMID
31570689
发布时间
2021-01-10
- 浏览3
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文